BIT 3.23% 3.0¢ biotron limited

Thoughts, page-13

  1. 233 Posts.
    Thanks Fingers. What makes you say BIT will be a winner? I'm keen to understand if you hold any interesting insight because it still appears to be an experimental drug.

    Also, do you know if Michelle Miller owns any direct equity interest in BIT (not options, but shares)?

    I find it insulting as a shareholder that as a CEO for 14 years, but she does not seem to have any direct interest in the equity. She also gets paid about $100k too much in my opinion.
    Last edited by lifeistooshort: 01/04/16
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.